We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Microcapsule Approach Reduces Toxic Side Effects of Chemotherapy

By LabMedica International staff writers
Posted on 25 May 2015
Print article
Image: Molecular model of the anti-cancer drug 5-fluorouracil (Photo courtesy of Wikimedia Commons).
Image: Molecular model of the anti-cancer drug 5-fluorouracil (Photo courtesy of Wikimedia Commons).
Cancer researchers have reduced chemotherapy's toxic side effects by using nanoporous capsules to transport an enzyme to the site of a tumor where it is activated by a selective heating process to convert a pro-drug into a toxic anticancer agent.

Investigators at Dartmouth College (Hanover, NH, USA) genetically engineered Escherichia coli bacteria to express high levels of the enzyme cytosine deaminase, which converts cytosine and water into uracil and ammonia, at elevated temperatures, under the transcriptional control of a thermo-regulatory lambd-apL-cI857 promoter cassette.

The investigators encapsulated the modified E.coli together with magnetic iron oxide nanoparticles in immunoprotective alginate microcapsules. Following take up of the microcapsules by tumor cells, cytosine deaminase expression in the E. coli was triggered remotely by alternating magnetic field (AMF)-induced hyperthermia. When AMF warmed the magnetic iron oxide nanoparticles to 42 degrees Celsius, the high temperature activated the cytosine deaminase produced by the bacteria, which then catalyzed the conversion of nontoxic 5-fluorocytosine to 5-fluorouracil (5FU). 5-FU is a thymidylate synthase (TS) inhibitor that interrupts the action of this enzyme and by doing so blocks synthesis of the pyrimidine thymidine, which is a nucleoside required for DNA replication.

Results published in the March 25, 2015, online edition of the Journal of Biotechnology revealed that the combination of 5-fluorocytosine with AMF-activated microcapsules demonstrated tumor cell cytotoxicity comparable to direct treatment with 5-fluorouracil chemotherapy but without the toxic systemic side effects.

"We have engineered cells that locally convert a nontoxic substance into an antitumor agent," said senior author Dr. Barjor Gimi, associate professor of radiology and of medicine at Dartmouth College. "We can encapsulate cells in nanoporous capsules, which ensures the cells are localized and immunoisolated. This immunoisolated micro-factory can remain in the tumor, providing a permanent and renewable source of therapeutic molecules for long-term cancer management."

Related Links:

Dartmouth College


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Unit-Dose Packaging solution
HLX
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit
New
Automated Nucleic Acid Extractor
eLab

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The bowel cancer breakthrough could result in better treatment outcomes (Photo courtesy of 123RF)

New RNA Molecules Can Help Predict Bowel Cancer Return Recurrence

Colorectal cancer accounts for 10% of all cancer-related deaths worldwide and was ranked as the second most common cause of cancer death in the United States in 2022. Currently, clinicians face diagnostic... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image

AI-Based Method Shows Promise for Pathological Diagnosis of Hereditary Kidney Diseases

Alport syndrome is a hereditary kidney disorder characterized by kidney dysfunction, sensorineural hearing loss, and ocular abnormalities. Early in the disease, patients experience hematuria, which is... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.